| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 49.2457 | 46 |
| GSM780708 | Untreated after 4 days (C2_1) | 48.0356 | 41 |
| GSM780709 | Untreated after 4 days (C3_1) | 54.5318 | 59 |
| GSM780719 | Untreated after 4 days (C1_2) | 53.0286 | 56 |
| GSM780720 | Untreated after 4 days (C2_2) | 49.0862 | 45 |
| GSM780721 | Untreated after 4 days (C3_2) | 50.3172 | 49 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 46.9713 | 37 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 46.7006 | 35 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 47.2569 | 38 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 44.9225 | 27 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 47.9917 | 41 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 43.6988 | 21 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 48.0287 | 41 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 46.094 | 32 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 51.8892 | 54 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 45.9955 | 32 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 50.861 | 51 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 45.3447 | 29 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 50.3897 | 50 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 49.9982 | 48 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 43.8464 | 21 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 48.4266 | 43 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 53.4039 | 57 |